UBS analyst Amit Mehrotra upgraded Dover (DOV) to Buy from Neutral with a price target of $256, up from $200. The company’s organic growth can “step up” in 2026 after two years of cyclical challenges, the analyst tells investors in a research note. When coupled with management’s capital deployment capacity and cost discipline, Dover could post double digit annual earnings growth, contends UBS. The firm sees upside in the shares with Dover at a 20% discount to peers.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DOV:
- Dover upgraded to Buy from Neutral at UBS
- Dover price target raised to $240 from $225 at BofA
- Dover’s Strong Future Performance: Buy Rating Backed by Strategic Growth Initiatives and Market Opportunities
- Dover price target raised to $200 from $190 at Wells Fargo
- Dover initiated with a Neutral at BNP Paribas Exane